Aytu Biopharma Inc expected to post a loss of 37 cents a share - Earnings Preview

Aytu Biopharma

23/09/2022 21:14

* Aytu Biopharma Inc  AYTU.OQ   AYTU.O  is expected to show
a rise
in quarterly revenue when it reports  results on September 27. 
    * The Englewood Colorado-based  company is expected to
report  a
8.6% increase in revenue to $25.5 million from $23.48 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aytu Biopharma Inc
is for
a loss of 37 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aytu
Biopharma
Inc is $5.5​, above​ its last closing price of $0.19. ​​​

This summary was machine generated September 23 at 20:14 GMT. 
All figures in US dollars  unless otherwise stated